NR5A2 and malignant colon neoplasm: The results were also consistent with data from Gene-Cloud of Biotechnology Information (GCBI) database (https://www.gcbi.com.cn/gclib/html/index), which shows that NR5A2, PPARGC1A and LGALS4 were down-regulated in colon cancer (Supplementary Material S11).